Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in HIMS — Hims & Hers Health, Inc.

CIK 1390777 NEW YORK, NY
Back to HIMS Full portfolio

Position in HIMS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$46,220,165
+$18,392,513 QoQ
Shares Held
1,333,146
-0.5% QoQ
Ownership
0.571%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 507 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in HIMS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. HIMS ranks #9 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,322,319 $238,741,833
2 VTRS
Viatris Inc
 14,288,053 $226,894,274
3 UTHR
UNITED THERAPEUTICS Corp
 294,413 $159,521,790
4 NBIX
Neurocrine Biosciences Inc
 699,125 $117,830,519
5 ELAN
Elanco Animal Health Inc
 3,411,532 $83,957,795
6 TEVA
Teva Pharmaceutical Industries Ltd
 1,899,912 $64,369,013
7 ALKS
Alkermes plc.
 1,097,282 $57,497,573
8 LNTH
Lantheus Holdings, Inc.
 441,831 $49,016,724

All Filings in HIMS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,220,165 1,333,146
2026-03-31 $27,827,652 1,340,446
2025-12-31 $44,820,185 1,380,357
2025-09-30 $75,987,892 1,339,702
2025-06-30 $66,079,510 1,325,567
2025-03-31 $37,241,624 1,260,292
2024-12-31 $30,102,961 1,244,953
2024-09-30 $10,028,822 544,453
2024-06-30 $13,700,972 678,602
2024-03-31 $6,267,343 405,129
2023-12-31 $3,852,950 432,916
2023-09-30 $3,550,709 564,501
2023-06-30 $4,758,401 506,213
2023-03-31 $4,369,510 440,475
2022-12-31 $2,899,768 452,382
2022-09-30 $2,088,174 374,225
2022-06-30 $1,420,290 313,530
2022-03-31 $279,206 52,384
2021-12-31 $343,115 52,384
2021-09-30 $713,049 94,569
2021-06-30 $469,074 43,074
2021-03-31 $331,808 25,080